The drug lowered free IL-6 and hs-CRP levels but didn’t affect outcomes, raising doubts about the inflammatory hypothesis.

Shephal Doshi discusses the possibility of performing the procedure outside the hospital, touching on acceptable levels of ...

Experts hope the FAI score can become the next big tool in personalized risk assessment, though costs remain unknown.

In a pivot from personal safety measures, the multisociety effort calls on stakeholders to pursue a modern, standardized ...

Absent contraindications, optimal medical therapy for heart failure with preserved ejection fraction (HFpEF) should include a ...

Three countries with different systems achieved similar levels of control, indicating that efforts to lessen CV risk should ...

The 2026 dyslipidemia guidelines offer “a chance to save lives at scale.” But statins alone can’t solve the problem.

The Centers for Medicare & Medicaid Services is weighing whether to cover TAVI in asymptomatic severe aortic stenosis, as ...

Twenty years of data from New England highlight geographical challenges, which some say may merit a rethink of STEMI care.

This month: online GLP-1 concerns, psychological impact of wearables, sexual and gender minority health insights, and more.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Ami Bhatt and Jagat Narula discuss the global impact of rheumatic heart disease, its challenges, and ongoing efforts for ...